Navigation Links
NutraCea Announces Conference Call to Report Second Quarter Financial Results
Date:12/20/2007

PHOENIX, Aug. 10 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a leader in stabilized rice bran nutrient research and technology, announced today it will report its second quarter financial results on Tuesday, August 14, 2007, after the financial markets close. There will be a conference call on Wednesday, August 15, 2007 at 11:30 AM EDT with the investment community, featuring Brad Edson, Chief Executive Officer and President of NutraCea, Todd Crow, Chief Financial Officer, and Leo Gingras, Chief Operating Officer.

Interested parties may participate in the call by dialing 877-407-8037; international callers dial 201-689-8037. In addition, the conference call will be available via a webcast that can be accessed at: http://www.vcall.com/IC/CEPage.asp?ID=119950 and will be archived for 30 days.

About NutraCea

NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly owned subsidiary RiceX, the company manufacturers as well as distributes products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual property to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health-promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the Company's filings with the SEC and you can visit the NutraCea web site http://www.NutraCea.com.

Company Contact: Investor Relations Contact:

Margie Adelman
'/>"/>

SOURCE NutraCea
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. NutraCea Appoints Financial Relations Board as New Investor Relations Firm
2. NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)....Y.,Nov.27/PRNewswire-USNewswire/--Preventingdisea...everyyear,newvaccinesarebeingaddedtoassistindiseas...eperiodoftime?And,ifnot,whenareadditional,boosters...,sissueofPediatrics,theJournaloftheAmericanAcademy...esterGeneralResearchInstitute,basedatRochesterGene...
(Date:11/27/2009)... XenaCare Holdings has announced that it has...tion, one of the largest nonprofit organizations d...ducation. , Delray Beach,..., Inc. (OTCBB: XCHO), a company specializing in th...althcare products, has announced today that is has...
(Date:11/27/2009)....27/PRNewswire/-- Allrecipes.com , theworld,s#1fo...rs,withmorethan2.8millionvisitorsthedaybeforeThank...biggestfoodholidayoftheyear.TheaverageThanksgiving...centincreasefromlastyear,sfeast.AccordingtotheAllr...opularThanksgivingrecipe,acontrastfromlastyear,spo...
(Date:11/27/2009)... Specialist manufacturers who use medical lo... millions of dollars by bringing in technology par...ng numbers of pro-active medical manufacturers are...pt stage of their projects, ensuring that progress...ses or potentially outdated technology. , ...
(Date:11/26/2009)....J.,Nov.27/PRNewswire/--Thediabetespopulationinthe...nnualmedicalspendingonthediseaseisprojectedtohit$3...publishedintheDecemberissueof DiabetesCare .TheNat...mofNovoNordisk,commissionedtheanalysisbyateamfromt...t,thenumberofAmericanslivingwithdiabeteswillrisefr...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3
...e Senior Living Inc. (NYSE: BKD ) announced toda...to a Second Amended and Restated Credit Agreement....million revolving loan facility and matures in Aug... the aggregate. The letter of credit facilities m...
...in Shapiro, PhD, have collaborated for 20 years to...center at Barrow Neurological Institute at St. Jos...dedicated patient care and research, the Shapiros ... allow Barrow to hire the best and the brightest t...
... MD Salon & Hair Replacement Center, Hair Fant...cement services for clients battling with hair los... Greenbelt, MD (PRWEB) February 27, 2009 -- ...amage, side effects from medication, iron or zinc ...
...utes to a Healthier, More Productive Practice , ,...ented integration of technology and is well-positi... The new A-dec 300 system offers customers a mid-l...cts. , , (Photo: http://www.newscom.com/cgi-bi...
...n of Wound Care and Ophthalmics Business of Unomed...ble Healthcare Partners ("RoundTable"), an operati...y on the healthcare industry, announced today that...cal Limited ("Unomedical") based in Redditch, U.K....
... global clinical research organization announced t...post of Director, Late Phase, Europe. , , Ms. T...w position in Chiltern,s global Late Phase Organiz...operational side of management in both industries....
Other Medicine News:Health News:Brookdale Amends and Extends Corporate Line of Credit 2Health News:Brookdale Amends and Extends Corporate Line of Credit 3Health News:A lifetime of paying it forward 2Health News:Inspired Cancer Survivor Launches Customized Hair Replacement ,Techniques at Award-Winning Hair Salon 2Health News:New A-dec 300(TM) Offers Dentists an Innovative Equipment Solution 2Health News:RoundTable Healthcare Partners Leads Portfolio Company Add-On Acquisition 2Health News:RoundTable Healthcare Partners Leads Portfolio Company Add-On Acquisition 3Health News:Chiltern Appoints Jane Turner as Late Phase Director for Europe 2
(Date:11/25/2009)...v.25/PRNewswire/--BioTrendsResearchGroup,Inc.relea...t,thefirstinamulti-phasesyndicatedmarketresearchpr...lara,fromproductlaunchthroughthefirstsixmonthsofav...informationfrom75uniqueDermatologistsandqualitativ...nduseofStelara,obstaclestouse,typicalpatienttypes,...
(Date:11/25/2009)...Md.,Nov.25/PRNewswire-USNewswire/--RemediumTechnol...thatstopsseverebleeding,wonfirstprizeand$10,000int...rityChallenge2009,companyofficialsannouncetoday. ,...rld,Remedium,steampitchedtheirinventionattheGSCSec...ss. ,, Remedium( www.remediumtechnologies.com )...
(Date:11/25/2009)...,Nov.25/PRNewswire-Asia-FirstCall/--ChinaSkyOne,Me...daq: CSKI ),a,leadingfullyintegratedpharmaceutical...sinthePeople,sRepublicofChina("PRC"),today,announc...stitutefor,theControlofPharmaceuticalandBiological...s:itsDiagnosticKitforHumanProstateSpecific,Antigen...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3REPEAT 3A Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positiv 57712 1REPEAT 3A Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positiv 57712 2REPEAT 3A Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positiv 57712 3U S Census Bureau Daily Feature for Sept 20 57708 1Strain on nanocrystals could yield colossal results 14156 1Strain on nanocrystals could yield colossal results 14156 2Strain on nanocrystals could yield colossal results 14156 3
...lls Inc. (BCI), a,biopharmaceutical company utiliz...p compounds that promote the growth of new neurons... diseases, announced today that it has,initiated a...didate,BCI-540, for the treatment of depression wi... expressed by our clinical,investigators who view ...
...Predictable, Extended Exposure with Sustained- ...O, April 17 Data from the first pivotal study of,...ional compound to treat,Restless Legs Syndrome (RL...toms of moderate-to-severe primary RLS compared to...ministered once-daily for 12 weeks., Data from th...
Other Medicine Technology:BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety 2Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 2Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 3Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 4Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 5Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 6
ABX Micros IM Hematology Analyzers
Sequitor™ Steerable Guidewire
Rio™ Aspiration Catheter
Reference Lab Interface (RLI)©
Medicine Products: